Literature DB >> 18927437

Functional assessment of perforin C2 domain mutations illustrates the critical role for calcium-dependent lipid binding in perforin cytotoxic function.

Ramon Urrea Moreno1, Juana Gil, Carmen Rodriguez-Sainz, Elena Cela, Victor LaFay, Brian Oloizia, Andrew B Herr, Janos Sumegi, Michael B Jordan, Kimberly A Risma.   

Abstract

Perforin-mediated lymphocyte cytotoxicity is critical for pathogen elimination and immune homeostasis. Perforin disruption of target cell membranes is hypothesized to require binding of a calcium-dependent, lipid-inserting, C2 domain. In a family affected by hemophagocytic lymphohistiocytosis, a severe inflammatory disorder caused by perforin deficiency, we identified 2 amino acid substitutions in the perforin C2 domain: T435M, a previously identified mutant with disputed pathogenicity, and Y438C, a novel substitution. Using biophysical modeling, we predicted that the T435M substitution, but not Y438C, would interfere with calcium binding and thus cytotoxic function. The capacity for cytotoxic function was tested after expression of the variant perforins in rat basophilic leukemia cells and murine cytotoxic T lymphocytes. As predicted, cells transduced with perforin-T435M lacked cytotoxicity, but those expressing perforin-Y438C displayed intact cytotoxic function. Using novel antibody-capture and liposome-binding assays, we found that both mutant perforins were secreted; however, only nonmutated and Y438C-substituted perforins were capable of calcium-dependent lipid binding. In addition, we found that perforin-Y438C was capable of mediating cytotoxicity without apparent proteolytic maturation. This study clearly demonstrates the pathogenicity of the T435M mutation and illustrates, for the first time, the critical role of the human perforin C2 domain for calcium-dependent, cytotoxic function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18927437      PMCID: PMC2615650          DOI: 10.1182/blood-2008-08-172924

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  35 in total

Review 1.  Delivering the kiss of death.

Authors:  Christina M Trambas; Gillian M Griffiths
Journal:  Nat Immunol       Date:  2003-05       Impact factor: 25.606

2.  Characterisation of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with haemophagocytic lymphohistiocytosis.

Authors:  S Molleran Lee; J Villanueva; J Sumegi; K Zhang; K Kogawa; J Davis; A H Filipovich
Journal:  J Med Genet       Date:  2004-02       Impact factor: 6.318

3.  A91V is a polymorphism in the perforin gene not causative of an FHLH phenotype.

Authors:  Udo Zur Stadt; Karin Beutel; Belinda Weber; Hartmut Kabisch; Reinhard Schneppenheim; Gritta Janka
Journal:  Blood       Date:  2004-09-15       Impact factor: 22.113

4.  Perforin gene defects in familial hemophagocytic lymphohistiocytosis.

Authors:  S E Stepp; R Dufourcq-Lagelouse; F Le Deist; S Bhawan; S Certain; P A Mathew; J I Henter; M Bennett; A Fischer; G de Saint Basile; V Kumar
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

5.  Novel perforin mutation in a patient with hemophagocytic lymphohistiocytosis and CD45 abnormal splicing.

Authors:  James McCormick; Darren R Flower; Stephan Strobel; Diana L Wallace; Peter C L Beverley; Elma Z Tchilian
Journal:  Am J Med Genet A       Date:  2003-03-15       Impact factor: 2.802

6.  Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation.

Authors:  Harutaka Katano; Mir A Ali; Andriani C Patera; Marta Catalfamo; Elaine S Jaffe; Hiroshi Kimura; Janet K Dale; Stephen E Straus; Jeffrey I Cohen
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

7.  Cytolytic activity of purified cytoplasmic granules from cytotoxic rat large granular lymphocyte tumors.

Authors:  P A Henkart; P J Millard; C W Reynolds; M P Henkart
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

8.  An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder.

Authors:  Michael B Jordan; David Hildeman; John Kappler; Philippa Marrack
Journal:  Blood       Date:  2004-04-06       Impact factor: 22.113

Review 9.  The MACPF/CDC family of pore-forming toxins.

Authors:  Carlos J Rosado; Stephanie Kondos; Tara E Bull; Michael J Kuiper; Ruby H P Law; Ashley M Buckle; Ilia Voskoboinik; Phillip I Bird; Joseph A Trapani; James C Whisstock; Michelle A Dunstone
Journal:  Cell Microbiol       Date:  2008-06-28       Impact factor: 3.715

10.  The functional basis for hemophagocytic lymphohistiocytosis in a patient with co-inherited missense mutations in the perforin (PFN1) gene.

Authors:  Ilia Voskoboinik; Marie-Claude Thia; Annette De Bono; Kylie Browne; Erika Cretney; Jacob T Jackson; Phillip K Darcy; Stephen M Jane; Mark J Smyth; Joseph A Trapani
Journal:  J Exp Med       Date:  2004-09-14       Impact factor: 14.307

View more
  10 in total

1.  Intracellular trafficking of perforin: to thwart a killer.

Authors:  Christopher Froelich; Sunil Metkar
Journal:  Immunity       Date:  2011-06-24       Impact factor: 31.745

2.  Real-time detection of CTL function reveals distinct patterns of caspase activation mediated by Fas versus granzyme B.

Authors:  Jinzhu Li; Sarah K Figueira; Alexandra C A Vrazo; Brock F Binkowski; Braeden L Butler; Yasuhiro Tabata; Alexandra Filipovich; Michael B Jordan; Kimberly A Risma
Journal:  J Immunol       Date:  2014-06-13       Impact factor: 5.422

3.  The structural basis for membrane binding and pore formation by lymphocyte perforin.

Authors:  Ruby H P Law; Natalya Lukoyanova; Ilia Voskoboinik; Tom T Caradoc-Davies; Katherine Baran; Michelle A Dunstone; Michael E D'Angelo; Elena V Orlova; Fasséli Coulibaly; Sandra Verschoor; Kylie A Browne; Annette Ciccone; Michael J Kuiper; Phillip I Bird; Joseph A Trapani; Helen R Saibil; James C Whisstock
Journal:  Nature       Date:  2010-10-31       Impact factor: 49.962

4.  Perforin rapidly induces plasma membrane phospholipid flip-flop.

Authors:  Sunil S Metkar; Baikun Wang; Elena Catalan; Gregor Anderluh; Robert J C Gilbert; Julian Pardo; Christopher J Froelich
Journal:  PLoS One       Date:  2011-09-12       Impact factor: 3.240

5.  Perforin gene transfer into hematopoietic stem cells improves immune dysregulation in murine models of perforin deficiency.

Authors:  Marlene Carmo; Kimberly A Risma; Paritha Arumugam; Swati Tiwari; Adrianne E Hontz; Claudia A Montiel-Equihua; Maria E Alonso-Ferrero; Michael P Blundell; Axel Schambach; Christopher Baum; Punam Malik; Adrian J Thrasher; Michael B Jordan; H Bobby Gaspar
Journal:  Mol Ther       Date:  2014-12-19       Impact factor: 11.454

Review 6.  Finding a Balance between Protection and Pathology: The Dual Role of Perforin in Human Disease.

Authors:  Robin C Willenbring; Aaron J Johnson
Journal:  Int J Mol Sci       Date:  2017-07-25       Impact factor: 5.923

7.  Lipid specificity of the immune effector perforin.

Authors:  Adrian W Hodel; Jesse A Rudd-Schmidt; Joseph A Trapani; Ilia Voskoboinik; Bart W Hoogenboom
Journal:  Faraday Discuss       Date:  2021-12-24       Impact factor: 4.008

Review 8.  A Pore Idea: the ion conduction pathway of TMEM16/ANO proteins is composed partly of lipid.

Authors:  Jarred M Whitlock; H Criss Hartzell
Journal:  Pflugers Arch       Date:  2016-01-06       Impact factor: 3.657

9.  Modulatory effects of perforin gene dosage on pathogen-associated blood-brain barrier (BBB) disruption.

Authors:  Robin C Willenbring; Fang Jin; David J Hinton; Mike Hansen; Doo-Sup Choi; Kevin D Pavelko; Aaron J Johnson
Journal:  J Neuroinflammation       Date:  2016-08-31       Impact factor: 8.322

10.  Human perforin gene variation is geographically distributed.

Authors:  Robin C Willenbring; Yasuhiro Ikeda; Larry R Pease; Aaron J Johnson
Journal:  Mol Genet Genomic Med       Date:  2017-12-07       Impact factor: 2.183

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.